Cargando…
Prevalence and Incidence of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype in the United States Estimated in a Large Claims Database Analysis
INTRODUCTION: Many fibrosing interstitial lung diseases (ILDs) develop a chronic progressive phenotype. While idiopathic pulmonary fibrosis, which is always progressive, is well characterized with established treatment options, the epidemiology of other chronic fibrosing ILDs with a progressive phen...
Autores principales: | Olson, Amy L., Patnaik, Padmaja, Hartmann, Nadine, Bohn, Rhonda L., Garry, Elizabeth M., Wallace, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8279991/ https://www.ncbi.nlm.nih.gov/pubmed/34156606 http://dx.doi.org/10.1007/s12325-021-01786-8 |
Ejemplares similares
-
Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis
por: Olson, Amy L., et al.
Publicado: (2022) -
Estimation of the Prevalence of Progressive Fibrosing Interstitial Lung Diseases: Systematic Literature Review and Data from a Physician Survey
por: Olson, Amy, et al.
Publicado: (2020) -
The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype
por: Olson, Amy L., et al.
Publicado: (2018) -
Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA
por: Olson, Amy L., et al.
Publicado: (2020) -
Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)